Inventor
HORNS STEFAN
CH11 patents
⚠️ This page may combine multiple inventors who share the name “HORNS STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
9 patentsUS9434715B2Sep 6, 2016
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV19 citations91
US8859575B2Oct 14, 2014
Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
JANSSEN PHARMACEUTICA NV5 citations82
US9278952B2Mar 8, 2016
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV1 citations61
US8350040B2Jan 8, 2013
Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2- methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
JANSSEN PHARMACEUTICA NV2 citations58
US9663497B2May 30, 2017
Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations50
US8039628B2Oct 18, 2011
Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino) ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
JANSSEN PHARMACEUTICA NV1 citations48
US8895762B2Nov 25, 2014
Process for the preparation of sulfamide derivatives
JANSSEN PHARMACEUTICA NV1 citations45
US10100035B2Oct 16, 2018
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same
JANSSEN PHARMACEUTICA NV0 citations43
US9796699B2Oct 24, 2017
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same
JANSSEN PHARMACEUTICA NV0 citations43